Organization
University of Texas Southwestern Medical Center at Dallas, Dallas, TX
15 abstracts
Abstract
SWOG S1011: A phase III surgical trial to evaluate the benefit of a standard versus an extended lymphadenectomy performed at time of radical cystectomy for muscle invasive urothelial cancer.Org: UT Health San Antonio, San Antonio, TX, The Ohio State University, Columbus, OH, USC/Norris Comprehensive Cancer Center, Los Angeles, CA, University of Chicago Medical Center, Chicago, IL, SWOG Cancer Research Network, San Antonio, TX,
Abstract
Incorporation of triapine (T) with cisplatin chemoradiation (CRT) for locally advanced cervical and vaginal cancer: Results from NRG-GY006, a phase III randomized trial.Org: O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham School of Medicine, Clinical Trial Development Division, Roswell Park Comprehensive Cancer Center, Stephenson Cancer Center/University of Oklahoma Health Sciences Center and Sarah Cannon Research Institute, University of Oklahoma Health Sciences Center,
Abstract
NRG-LU002: Randomized phase II/III trial of maintenance systemic therapy versus local consolidative therapy (LCT) plus maintenance systemic therapy for limited metastatic non-small cell lung cancer (NSCLC).Org: Memorial Sloan Kettering Cancer Center, NRG Oncology Statistics and Data Management Center, American College of Radiology, Philadelphia, PA, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, Washington University School of Medicine in St. Louis, Washington University School of Medicine,
Abstract
CINSARC score use in pediatric non-rhabdomyosarcoma soft tissue sarcoma (NRSTS) in the Children’s Oncology Group (COG) studies ARST0332 and ARST1321.Org: Children's Hospital of Philadelphia, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, Children's Oncology Group Statistics and Data Center, University of Florida, Massachusetts General Hospital, Seattle Children's Hospital,
Abstract
Neoadjuvant targeted therapy in early resectable HER2-mutant lobular breast cancer.Org: Vanderbilt-Ingram Cancer Center, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, UT Southwestern Simmons Comprehensive Cancer Center,
Abstract
Administrative burden of establishing health care coverage for the uninsured and its impact on timely access to care.Org: UT Southwestern Medical Center, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, Rutgers-RWJBarnabas Health,
Abstract
Unveiling the interplay of social factors in cancer survivorship: A comprehensive social determinants of health (SDOH) profile analysis.Org: Tsinghua University, Beijing InnoCare Pharma Tech, China National Biotec Group, University of Oklahoma Health Sciences Center, Oklahoma City,
Abstract
Racial disparities and survival outcome of patients with locally advanced cervix cancer in the international randomised phase 3 OUTBACK trial (ANZGOG 0902, RTOG 1174, NRG 0274).Org: NHMRC Clinical Trials Centre, The University of Sydney, Louisiana State University Health Sciences Center, Department of Gynecologic Oncology, University of California, Los Angeles,
Abstract
Safety and efficacy of osimertinib plus consolidative stereotactic ablative radiation (SABR) in advanced EGFR mutant non-small cell lung cancer (NSCLC): Results from a multi-center phase II trial.Org: UT Southwestern Medical Center, Dallas, City of Hope National Comprehensive Cancer Center, Duarte, CA, Memorial Sloan Kettering Cancer Center,
Abstract
Trends in human papilloma virus vaccination uptake by sex and race/ethnicity among US adolescents and young adults, 2011-2020.Org: University of Florida Department of Health Outcomes and Biomedical Informatics, Gainesville, FL, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, Dallas, TX, Baylor College of Medicine,
Abstract
Evorpacept plus enfortumab vedotin in patients (Pts) with locally advanced or metastatic urothelial carcinoma (la/mUC): Phase 1a dose escalation results.Org: Memorial Sloan Kettering Cancer Center, Department of Medicine, Icahn School of Medicine at Mount Sinai, Division of Hematology/Oncology, Department of Medicine, University Of Toledo, University of Washington and Fred Hutchinson Cancer Research Centre, Fred Hutchinson Cancer Center,
Abstract
Impact of COVID-19 on referrals to outpatient palliative care for patients with advanced cancer in a safety-net health system.Org: UT Southwestern Medical Center, University of Texas Southwestern Medical Center at Dallas, Dallas, TX,
Abstract
Impact of β-adrenergic blockade on efficacy of immunotherapy in patients with metastatic clear cell renal cell carcinoma.Org: Dana-Farber Cancer Institute, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, Beth Israel Deaconess Medical Center, Yale University School of Medicine, The Lank Center for Genitourinary Oncology,
Abstract
Costs and access barriers to ondansetron: A national analysis of Medicare part D and Medicare Advantage plans.Org: Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, Dallas, TX, UT Southwestern Medical Center,
Abstract
CemiplimAb-rwlc survivorship and epidemiology (CASE): A prospective study of safety and efficacy of cemiplimab in patients with advanced basal cell carcinoma in a real-world setting.Org: Charleston Oncology, The Melanoma And Skin Cancer Institute, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, Department of Hematology and Oncology, Miami Cancer Institute/Baptist Health South Florida, Brigham and Women's Hospital/Massachusetts General Hospital,